BAFNA PHARMACEUTICALS
|
BAFNA PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹4.15 Cr | ₹7.35 Cr | ₹12 Cr | ₹5.19 Cr | ₹5.83 Cr |
| Adjustment | ₹10 Cr | ₹7.59 Cr | ₹7.88 Cr | ₹5.50 Cr | ₹3.82 Cr |
| Changes In working Capital | ₹7.55 Cr | ₹-5.28 Cr | ₹-14 Cr | ₹-0.80 Cr | ₹-23 Cr |
| Cash Flow after changes in Working Capital | ₹22 Cr | ₹9.66 Cr | ₹5.08 Cr | ₹9.90 Cr | ₹-14 Cr |
| Cash Flow from Operating Activities | ₹22 Cr | ₹9.48 Cr | ₹4.95 Cr | ₹9.73 Cr | ₹-14 Cr |
| Cash Flow from Investing Activities | ₹-21 Cr | ₹-15 Cr | ₹-7.49 Cr | ₹-6.54 Cr | ₹-5.35 Cr |
| Cash Flow from Financing Activities | ₹1.06 Cr | ₹-0.85 Cr | ₹10 Cr | ₹-4.81 Cr | ₹12 Cr |
| Net Cash Inflow / Outflow | ₹2.04 Cr | ₹-6.41 Cr | ₹7.64 Cr | ₹-1.63 Cr | ₹-6.68 Cr |
| Opening Cash & Cash Equivalents | ₹1.40 Cr | ₹7.81 Cr | ₹0.17 Cr | ₹1.80 Cr | ₹8.48 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹3.43 Cr | ₹1.40 Cr | ₹7.81 Cr | ₹0.17 Cr | ₹1.80 Cr |
Compare Cashflow Statement of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹621.9 Cr | -7.7% | 16.8% | 218.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -7.7% |
16.8% |
218.7% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses